Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing Capsules and Guben Kechuan Granules for Stable Bronchiectasis
NCT07114120Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bailing jiaonang and Guben Kechuan in bronchiectasis (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Number of acute exacerbations at 48 weeks. Started Jul 2025; status: recruiting.
02
Drugs
bailing jiaonangGuben Kechuan
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07114120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07114120.